Status | Study |
Terminated |
Study Name: Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma Condition: 714leukemia Lymphoma Date: 2008-05-02 Interventions: Drug: Bortezomib |
Completed |
Study Name: Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Condition: Prolymphocytic Leukemia Date: 2006-01-16 Interventions: Biological: alemtuzumab Drug: cyclophospha |
Completed |
Study Name: Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD) Condition: Chronic Lymphoproliferative Diseases Date: 2005-07-25 Interventions: Drug: GRN163L Weekly intravenous infusion |
Active, not recruiting |
Study Name: Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia Condition: B-Cell Prolymphocytic Leukemia Chronic Lymphocytic Leukemia Date: 2003-05-06 Interventions: Drug: Cyclosporine Given PO |
Active, not recruiting |
Study Name: Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma Condition: Prolymphocytic Leukemia Recurrent Adult Hodgkin Lymphoma R Date: 2000-06-02 Interventions: Procedure: Autologous Hematopoietic Stem Cell Transplantation |